Co-trimoxazole (trimethoprim with sulfamethoxazole)

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Co-trimoxazole (trimethoprim with sulfamethoxazole) and local guidelines before prescribing.

Antibiotic (folate antagonist combination)

Mechanism

Sequential folate synthesis blockade (sulfamethoxazole and trimethoprim).

Uses

Pneumocystis jirovecii pneumonia (treatment and prophylaxis), nocardiosis, toxoplasmosis prophylaxis, MRSA skin infection, resistant UTI.

Dosing

Side effects

Nausea, rash, hyperkalaemia, marrow suppression, Stevens-Johnson syndrome, raised creatinine.

Interactions

Methotrexate (marrow toxicity), warfarin, phenytoin, ACE inhibitors and spironolactone (hyperkalaemia), ciclosporin.

Contraindications and cautions

Sulfonamide allergy, severe liver or renal disease, porphyria, blood dyscrasia

Monitoring

FBC, U&E, rash

Pregnancy and breastfeeding

Avoid in first trimester and at term

Renal and hepatic impairment

Reduce dose if CrCl below 30

Overdose and reversal

Folinic acid for marrow toxicity

Special advice

Check potassium and creatinine; hydrate; avoid in G6PD deficiency and sulfonamide allergy; high-dose PJP regimens need close monitoring.

More from the textbook: uses, cautions and other points
Where it is discussed in the book